Ann: $6.6 million Placement to advance clinical trial pipeline, page-69

Let's hope it will pay out well for you and other 0.4c buyers. The problem is that if approved at the EGM hundreds of millions of 0.4c shares could be placed for sale due to the tradable attached free oppies. And if not approved, then a huge sell off must be expected. In both cases, not much of a chance to get the sp up without a huge anns.

Of course, anything is possible, there could always be an anns out of the woodwork sending the sp skywards. But we both know by holding RAD how difficult it is to get the sp up where it belongs even when big pharma paid 2-3 x the current sp.

GLTA